Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.

Clinical pharmacology and therapeutics - 1 Sept 2017

Harada S, Zhou Y, Duncan S, Armstead A R, Coshatt G M, Dillon C, Brott B C, Willig J, Alsip J A, Hillegass W B, Limdi N A

Abstract excerpt

Precision medicine entails tailoring treatment based on patients' unique characteristics. As drug therapy constitutes the cornerstone of treatment for most chronic diseases, pharmacogenomics (PGx), the study of genetic variation influencing individual response to drugs, is an important component of precision medicine. Over the past decade investigations have identified genes and single-nucleotide polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alabama
Share to Decision Support Systems, Clinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Pharmacogenetics

Share to Platelet Aggregation Inhibitors

Share to Point-of-Care Systems

Share to Precision Medicine

Share to Universities

Source

Open in PubMed Open full text

Identifiers

PMID: 28124392
DOI: 10.1002/cpt.631
PMCID: PMC5526751

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.PMID 28124392Read ↗

Clinical PharmacogenomicsSemantic proximity Read ↗

Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.Semantic proximity Read ↗

A surveillance tool to support quality assurance and research in personalized medicine.Semantic proximity Read ↗

Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.Semantic proximity Read ↗

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.Semantic proximity Read ↗

CLINICAL IMPLEMENTATION OF PREEMPTIVE PHARMACOGENOMICS TESTING FOR PERSONALIZED MEDICINE AT AN ACADEMIC MEDICAL CENTERSemantic proximity Read ↗

Hypertension precision medicine: the promise and pitfalls of pharmacogenomicsSemantic proximity Read ↗

The future of precision medicine: towards a more predictive personalized medicine.Semantic proximity Read ↗

Antiplatelet therapy guided by CYP2C19 point-of-care pharmacogenetics plus multidimensional treatment decisions.Semantic proximity Read ↗

Give genotype-guided dual antiplatelet therapy a second CHANCE.Semantic proximity Read ↗

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.Semantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.